AzTrials
AzTrials

StrokeNCT01969097

Efficacy Basics of Bihemispheric Motorcortex Stimulation After Stroke

A study testing tDCS and Motor training in people with Stroke and Hemiparesis, run by Charite University, Berlin, Germany at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the study is to investigate whether the combination of bihemispheric ("dual") transcranial direct current stimulation (tDCS) and motor training on 5 consecutive days facilitates motor recovery in chronic stroke. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Stroke, Hemiparesis
What is being tested?
tDCS and Motor training
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
50 participants
Where
1 siteGermany
Study dates
May 2012to Dec 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • chronic stroke (>6 months after stroke)
  • age: 18 to 80 years
  • non-hemorrhagic or hemorrhagic stroke

Who cannot join

  • more than 1 stroke
  • severe alcohol disease or drug abuse, severe psychiatric disease like depression or psychosis
  • severe cognitive deficits
  • severe untreated medical conditions
  • other neurologic diseases
  • severe microangiopathy
  • pregnancy

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Charite Universitätsmedizin Berlin

    Berlin, 10117

Other trials in Germany

About this study

The aim of the study is to investigate whether the combination of bihemispheric ("dual") transcranial direct current stimulation (tDCS) and motor training on 5 consecutive days facilitates motor recovery in chronic stroke. Results will be compared to a matched group of patients undergoing anodal tDCS as well as a control group receiving sham tDCS. Functional and structural magnetic resonance imaging (MRI) before/after the intervention and during a 3 month follow-up will help investigating neural correlates of expected changes in motor function of the affected upper extremity.

Conditions
Stroke, Hemiparesis
Being tested
tDCS, Motor training
Keywords
Stroke, Hemiparesis, tDCS, Motor cortex
Medical subject headings
Stroke, Paresis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • tDCSDevice

    transcranial direct current stimulation (tDCS)

  • Motor trainingBehavioural

    Motor training of the affected upper extremity (5 days, 25 min/day).

Study groups in NCT01969097
Study groupRoleWhat they receive
Dual tDCS + motor trainingExperimentalMotor training of the affected upper extremity combined with dual transcranial direct current stimulation (tDCS).
Receives: Device: tDCS; Behavioral: Motor training
Anodal tDCS + motor trainingActive comparatorMotor training of the affected upper extremity combined with anodal tDCS.
Receives: Device: tDCS; Behavioral: Motor training
Sham tDCS + motor trainingSham comparatorMotor training of the affected upper extremity combined with sham tDCS.
Receives: Device: tDCS; Behavioral: Motor training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Motor Function of the Affected Upper Extremity

    Effects of dual tDCS + training vs sham-tDCS + training on the motor function of the affected upper extremity (measured by standardized behavioral tests).

    Measured: Change from baseline after 5 days (immediately after intervention)

  2. Motor Function of the Affected Upper Extremity

    Effects of dual tDCS + training vs sham-tDCS + training on the motor function of the affected upper extremity (measured by standardized behavioral tests).

    Measured: change from baseline after 3 months

Secondary outcomes (4)
  1. Motor Function of the Affected Upper Extremity

    Effects of dual tDCS + training vs anodal tDCS + training on the motor function of the affected upper extremity (measured by standardized behavioral tests).

    Measured: After 5 days (immediately after intervention), after 3 months vs baseline (before intervention)

  2. Functional Magnetic Resonance Imaging

    Effects of dual tDCS + training vs anodal tDCS + training vs sham-tDCS + training on task-specific activations and functional connectivity (measured by functional Magnetic Resonance Imaging, fMRI).

    Measured: After 5 days (immediately after intervention), after 3 months vs baseline (before intervention)

  3. Diffusion Tensor Imaging

    Effects of dual tDCS + training vs anodal tDCS + training vs sham-tDCS + training on cerebral microstructure (measured by Diffusion Tensor Imaging, DTI).

    Measured: After 5 days (immediately after intervention), after 3 months vs baseline (before intervention)

  4. Transcranial Magnetic Stimulation

    Effects of dual tDCS + training vs anodal tDCS + training vs sham tDCS + training on excitability of the primary motor cortex (measured by Motor Evoked Potentials, MEP, using Transcranial Magnetic Stimulation, TMS).

    Measured: After 5 days vs baseline (before intervention)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Oct 2013 (estimated)
  2. Study startMay 2012
  3. Primary completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01969097
Sponsor's protocol ID
MotorCtx-Stroke-tDCS
Status last verified
Mar 2016
First submitted
7 Oct 2013
Last updated
17 Mar 2016
Results posted
No
Data monitoring committee
No

Publications

  • Lindenberg R, Renga V, Zhu LL, Nair D, Schlaug G. Bihemispheric brain stimulation facilitates motor recovery in chronic stroke patients. Neurology. 2010 Dec 14;75(24):2176-84. doi: 10.1212/WNL.0b013e318202013a. Epub 2010 Nov 10.

    PubMed 21068427
  • Lindenberg R, Nachtigall L, Meinzer M, Sieg MM, Floel A. Differential effects of dual and unihemispheric motor cortex stimulation in older adults. J Neurosci. 2013 May 22;33(21):9176-83. doi: 10.1523/JNEUROSCI.0055-13.2013.

    PubMed 23699528
  • Floel A. tDCS-enhanced motor and cognitive function in neurological diseases. Neuroimage. 2014 Jan 15;85 Pt 3:934-47. doi: 10.1016/j.neuroimage.2013.05.098. Epub 2013 May 30.

    PubMed 23727025
  • Taud B, Lindenberg R, Darkow R, Wevers J, Hofflin D, Grittner U, Meinzer M, Floel A. Limited Add-On Effects of Unilateral and Bilateral Transcranial Direct Current Stimulation on Visuo-Motor Grip Force Tracking Task Training Outcome in Chronic Stroke. A Randomized Controlled Trial. Front Neurol. 2021 Nov 11;12:736075. doi: 10.3389/fneur.2021.736075. eCollection 2021.

    PubMed 34858310
  • Elsner B, Kugler J, Pohl M, Mehrholz J. Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people after stroke. Cochrane Database Syst Rev. 2020 Nov 11;11(11):CD009645. doi: 10.1002/14651858.CD009645.pub4.

    PubMed 33175411

Questions about this trial

What is this clinical trial studying?

A study testing tDCS and Motor training in people with Stroke and Hemiparesis, run by Charite University, Berlin, Germany at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Mar 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Motor Function of the Affected Upper Extremity (time frame: Change from baseline after 5 days (immediately after intervention)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01969097, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Mar 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT01969097 | AzTrials